Sorry!! The article you are trying to read is not available now.
2013 Drug Stock Watch List Announced

New York, NY -- (ACCESSWIRE) -- 01/24/2013 -- Growing Stock Report iniates a 2013 Drug Stock Watch List and Investor Polls for the following Two Drug Stocks: Pfizer Inc. (NYSE:PFE) and Sanofi (NYSE:SNY).

Pfizer Inc. (NYSE:PFE) As of this writing up (+2.21%)

Pfizer Inc. (NYSE:PFE) a company that engages in the discovery, development, manufacture, and sale of medicines for people and animals worldwide that primarily offers Celebrex, Chantix/Champix, Lipitor, Lyrica, Premarin, Pristiq, and Viagra pharmaceutical products in the therapeutic and disease areas of Alzheimer’s disease, cardiovascular, erectile dysfunction, genitourinary, depressive disorder, pain, respiratory, and smoking cessation announced this morning Top-Line Efficacy Results From A Phase 4 Study Of PRISTIQ® (desvenlafaxine) For The Treatment Of Major Depressive Disorder In Adults, helping the stock rise (+2.21%) this morning, Pfizer Inc. (NYSE:PFE) is up (+31.28%) from it's 52-Week Low of $20.75 which it hit on 01/27/2012. Pfizer's stock price gain of (+31.28%) over this past year has prompted Growing Stock Report to Add Pfizer Inc. (NYSE:PFE) to their 2013 Drug Stock Watch List and Investor Polls.

Get PFE Poll & Consensus Report Here: http://www.growingstockreport.com/Survey.aspx?stock=PFE

Sanofi (NYSE:SNY) As of this writing up (+1.07%)

Sanofi (NYSE:SNY) a company that researches, develops, manufactures, and markets healthcare products worldwide who's principal pharmaceuticals include Lantus and Apidra analogs of human insulin recently announced that its epinephrine injection, Allerject, is available in Canada for the emergency treatment of anaphylactic reactions in patients at risk or with a history of anaphylaxis, Allerject is already approved in the US under the brand name Auvi-Q, currently epinephrine is the only first-line treatment for anaphylaxis. Sanofi (NYSE:SNY) is currently up (+46.96%) from it's 52-Week Low of $33.03 which it hit on 06/01/2012. Sanofi's stock price gain of (+46.96%) from it's 52-Week Low has prompted Growing Stock Report to Add Sanofi (NYSE:SNY) to their 2013 Drug Stock Watch List and Investor Polls.

Get SNY Poll & Consensus Report Here: http://www.growingstockreport.com/Survey.aspx?stock=SNY

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Stock, Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.Subscribe Here: http://www.GrowingStockReport.comDisclosure: GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:

Growing Stock Reporteditor@GrowingStockReport.com

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE